NeuroMetrix, Inc. (NASDAQ:NURO – Get Free Report) was the target of a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 15,800 shares, a decrease of 24.8% from the October 15th total of 21,000 shares. Based on an average trading volume of 19,600 shares, the days-to-cover ratio is presently 0.8 days. Approximately 1.1% of the shares of the stock are sold short.
NeuroMetrix Stock Down 0.8 %
Shares of NeuroMetrix stock traded down $0.03 during trading on Friday, hitting $3.76. 2,237 shares of the stock traded hands, compared to its average volume of 25,847. NeuroMetrix has a 52 week low of $2.66 and a 52 week high of $4.73. The firm’s fifty day moving average is $4.02 and its 200-day moving average is $3.86. The stock has a market cap of $7.67 million, a price-to-earnings ratio of -0.83 and a beta of 2.29.
NeuroMetrix (NASDAQ:NURO – Get Free Report) last released its earnings results on Tuesday, November 5th. The medical device company reported ($0.75) EPS for the quarter. The business had revenue of $0.59 million for the quarter. NeuroMetrix had a negative net margin of 203.71% and a negative return on equity of 42.56%. During the same quarter in the prior year, the company posted ($1.66) earnings per share.
Analyst Ratings Changes
Check Out Our Latest Stock Report on NURO
NeuroMetrix Company Profile
NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.
Featured Stories
- Five stocks we like better than NeuroMetrix
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Top-Performing Non-Leveraged ETFs This Year
- Best Aerospace Stocks Investing
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- How Technical Indicators Can Help You Find Oversold Stocks
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for NeuroMetrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroMetrix and related companies with MarketBeat.com's FREE daily email newsletter.